Auxly Cannabis Group Inc. (CBWTF)
OTCMKTS: CBWTF · Delayed Price · USD
0.0405
+0.0015 (3.79%)
May 2, 2024, 3:56 PM EDT - Market closed
Auxly Cannabis Group Revenue
In the year 2023, Auxly Cannabis Group had annual revenue of 101.08M CAD with 6.99% growth. Revenue in the quarter ending December 31, 2023 was 26.91M CAD with 9.03% year-over-year growth.
Revenue (ttm)
101.08M CAD
Revenue Growth
+6.99%
P/S Ratio
0.55
Revenue / Employee
273,924 CAD
Employees
369
Market Cap
40.56M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 101.08M | 6.61M | 6.99% |
Dec 31, 2022 | 94.47M | 10.64M | 12.70% |
Dec 31, 2021 | 83.83M | 33.03M | 65.03% |
Dec 31, 2020 | 50.80M | 42.44M | 508.19% |
Dec 31, 2019 | 8.35M | 7.61M | 1,018.07% |
Dec 31, 2018 | 747.00K | -630.99K | -45.79% |
Dec 31, 2017 | 1.38M | 1.15M | 495.93% |
Dec 31, 2016 | 231.23K | -25.98K | -10.10% |
Dec 31, 2015 | 257.21K | -17.84K | -6.49% |
Dec 31, 2014 | 275.05K | -95.02K | -25.68% |
Dec 31, 2013 | 370.07K | -2.83K | -0.76% |
Dec 31, 2012 | 372.90K | 14.08K | 3.92% |
Dec 31, 2011 | 358.82K | 2.30K | 0.64% |
Dec 31, 2010 | 356.53K | 38.64K | 12.15% |
Dec 31, 2009 | 317.89K | 82.81K | 35.22% |
Dec 31, 2008 | 235.08K | 39.78K | 20.37% |
Dec 31, 2007 | 195.30K | -9.21M | -97.92% |
Dec 31, 2006 | 9.41M | 1.61M | 20.60% |
Dec 31, 2005 | 7.80M | 3.97M | 103.52% |
Dec 31, 2004 | 3.83M | 2.01M | 110.29% |
Dec 31, 2003 | 1.82M | 214.04K | 13.30% |
Dec 31, 2002 | 1.61M | -588.42K | -26.78% |
Dec 31, 2001 | 2.20M | -407.67K | -15.65% |
Dec 31, 2000 | 2.61M | - | - |
Dec 31, 1999 | 0 | - | - |
Nov 30, 1998 | 0 | - | - |
Aug 31, 1997 | 1.00 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
CBWTF News
- 4 weeks ago - AUXLY ANNOUNCES COMPLETION OF CONVERSION OF OVER $123 MILLION OF PRINCIPAL AND INTEREST UNDER IMPERIAL DEBENTURE - PRNewsWire
- 5 weeks ago - AUXLY REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES OUTLOOK FOR 2024 - PRNewsWire
- 6 weeks ago - AUXLY TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON MARCH 25, 2024 - PRNewsWire
- 3 months ago - AUXLY COMPLETES AMENDMENT AND EXTENSION OF AUXLY LEAMINGTON CREDIT FACILITY - PRNewsWire
- 4 months ago - AUXLY ANNOUNCES NON-BINDING TERM SHEET TO EXTEND AUXLY LEAMINGTON CREDIT FACILITY FOR UP TO 3 YEARS AND THIRD INTERIM EXTENSION - PRNewsWire
- 5 months ago - AUXLY ANNOUNCES SECOND INTERIM EXTENSION OF AUXLY LEAMINGTON CREDIT FACILITY - PRNewsWire
- 6 months ago - AUXLY REPORTS Q3 2023 FINANCIAL RESULTS - PRNewsWire
- 6 months ago - AUXLY TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON NOVEMBER 13, 2023 - PRNewsWire